These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 33977463)
1. Antibiotics Therapy in the Multi-Resistant Patient. Blanco-Nistal MM; Fernández-Fernández JA Methods Mol Biol; 2021; 2296():423-439. PubMed ID: 33977463 [TBL] [Abstract][Full Text] [Related]
2. The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria. D'Agata EM; Dupont-Rouzeyrol M; Magal P; Olivier D; Ruan S PLoS One; 2008; 3(12):e4036. PubMed ID: 19112501 [TBL] [Abstract][Full Text] [Related]
3. The challenges of multi-drug-resistance in hepatology. Fernández J; Bert F; Nicolas-Chanoine MH J Hepatol; 2016 Nov; 65(5):1043-1054. PubMed ID: 27544545 [TBL] [Abstract][Full Text] [Related]
4. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Medina E; Pieper DH Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189 [TBL] [Abstract][Full Text] [Related]
5. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention. Tzialla C; Borghesi A; Pozzi M; Stronati M Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408 [TBL] [Abstract][Full Text] [Related]
6. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. Vivas R; Barbosa AAT; Dolabela SS; Jain S Microb Drug Resist; 2019; 25(6):890-908. PubMed ID: 30811275 [TBL] [Abstract][Full Text] [Related]
8. Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study. Gashaw M; Berhane M; Bekele S; Kibru G; Teshager L; Yilma Y; Ahmed Y; Fentahun N; Assefa H; Wieser A; Gudina EK; Ali S Antimicrob Resist Infect Control; 2018; 7():138. PubMed ID: 30479751 [TBL] [Abstract][Full Text] [Related]
9. Rational prioritization strategy allows the design of macrolide derivatives that overcome antibiotic resistance. König G; Sokkar P; Pryk N; Heinrich S; Möller D; Cimicata G; Matzov D; Dietze P; Thiel W; Bashan A; Bandow JE; Zuegg J; Yonath A; Schulz F; Sanchez-Garcia E Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34750269 [TBL] [Abstract][Full Text] [Related]
10. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens. David AA; Park SE; Parang K; Tiwari RK Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392 [TBL] [Abstract][Full Text] [Related]
11. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis. Baditoiu L; Axente C; Lungeanu D; Muntean D; Horhat F; Moldovan R; Hogea E; Bedreag O; Sandesc D; Licker M Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):71. PubMed ID: 29132352 [TBL] [Abstract][Full Text] [Related]
12. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776 [TBL] [Abstract][Full Text] [Related]
13. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008]. Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987 [TBL] [Abstract][Full Text] [Related]
14. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016. Mao T; Zhai H; Duan G; Yang H Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593 [TBL] [Abstract][Full Text] [Related]
15. An ancient solution to a modern problem. Davies JE; Behroozian S Mol Microbiol; 2020 Mar; 113(3):546-549. PubMed ID: 32185831 [TBL] [Abstract][Full Text] [Related]
16. Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review. Saadeh HA; Mubarak MS Curr Top Med Chem; 2017; 17(8):895-906. PubMed ID: 27697051 [TBL] [Abstract][Full Text] [Related]
17. Is screening patients for antibiotic-resistant bacteria justified in the Indian context? Bhattacharya S Indian J Med Microbiol; 2011; 29(3):213-7. PubMed ID: 21860099 [TBL] [Abstract][Full Text] [Related]
18. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do? Penchovsky R; Traykovska M Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754 [TBL] [Abstract][Full Text] [Related]
19. Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics. Lahmar A; Bedoui A; Mokdad-Bzeouich I; Dhaouifi Z; Kalboussi Z; Cheraif I; Ghedira K; Chekir-Ghedira L Microb Pathog; 2017 May; 106():50-59. PubMed ID: 27815129 [TBL] [Abstract][Full Text] [Related]